Showing results (791-800 of 4,505) with videos related to
Sort By:
Pageof 451
Advances in Therapy|February 6, 2016
Impact of Reduced Renal Function on the Glucose-Lowering Effects of Luseogliflozin, a Selective SGLT2 Inhibitor, Assessed by Continuous Glucose Monitoring in Japanese Patients with Type 2 Diabetes MellitusHideaki Jinnouchi, Kazunari Nozaki, Hirotaka Watase, et al.Advances in Therapy|January 4, 2016
Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 InhibitorsAmanda M Farr, John J Sheehan, Matthew Brouillette, et al.Advances in Therapy|January 7, 2016
SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment ModelAnton Petrov, Natalia Perekhvatova, Maxim Skulachev, et al.Advances in Therapy|October 27, 2015
Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi TechniqueToby M Maher, Moira K B Whyte, Rachel K Hoyles, et al.Advances in Therapy|October 27, 2015
Current Management of Primary Immune ThrombocytopeniaDrew Provan, Adrian C NewlandAdvances in Therapy|September 10, 2015
Prediction of Perioperative Death Following Surgery for Renal Cell Carcinoma with Vein Involvement: A Retrospective StudyMeryem Akkoyun, Axel S Merseburger, Mario W Kramer, et al.Advances in Therapy|September 16, 2015
Converging or Crossing Curves: Untie the Gordian Knot or Cut it? Appropriate Statistics for Non-Proportional Hazards in Decitabine DACO-016 Study (AML)Jörg Tomeczkowski, Ansgar Lange, Andreas Güntert, et al.Advances in Therapy|January 18, 2015
Current adjuvant therapeutic approaches for pancreatic cancerFusun Ozmen, Tevfik Tolga Şahin, M Mahir OzmenAdvances in Therapy|July 31, 2014
Advances in clinical cardiologyAndrew H McNeice, Neil M McAleavey, Ian B A MenownAdvances in Therapy|November 1, 2013
Dose conversion ratio in hemodialysis patients switched from darbepoetin alfa to PEG-epoetin beta: AFFIRM studyPeter Choi, Mourad Farouk, Nick Manamley, et al.Pageof 451